LI
KRYS icon

LRI Investments’s Krystal Biotech KRYS Stock Holding History

LRI Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372 Buy
+1
New +$299 ﹤0.01% 1608

Other funds holding KRYS

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LRI Investments's KRYS Position: Q2 2026 in Review

LRI Investments opened a new position in Krystal Biotech (KRYS) in Q2 2026: 1 share worth $372. The stake represents ﹤0.01% of the portfolio and ranks #1608 among its holdings.

117 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • LRI Investments held 1 share of Krystal Biotech worth $372 as of Q2 2026.
  • Krystal Biotech was a new LRI Investments position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1608 holding.
  • 117 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.